Inhibition of the Sodium-Hydrogen Exchanger With Cariporide to Prevent Myocardial Infarction in High-Risk Ischemic Situations: Main Results of the GUARDIAN Trial
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Background—The transmembrane sodium/hydrogen exchanger maintains myocardial cell pH integrity during myocardial ischemia but paradoxically may precipitate cell necrosis. The development of cariporide, a potent and specific inhibitor of the exchanger, prompted this investigation of the potential of the drug to prevent myocardial cell necrosis. Methods and Results—A total of 11 590 patients with unstable angina or non–ST-elevation myocardial infarction (MI) or undergoing high-risk percutaneous or surgical revascularization were randomized to receive placebo or 1 of 3 doses of cariporide for the period of risk. The trial failed to document benefit of cariporide over placebo on the primary end point of death or MI assessed after 36 days. Doses of 20 and 80 mg every 8 hours had no effect, whereas a dose of 120 mg was associated with a 10% risk reduction (98% CI 5.5% to 23.4%,P=0.12). With this dose, benefit was limited to patients undergoing bypass surgery (risk reduction 25%, 95% CI 3.1% to 41.5%,P=0.03) and was maintained after 6 months. No effect was seen on mortality. The rate of Q-wave MI was reduced by 32% across all entry diagnostic groups (2.6% versus 1.8%,P=0.03), but the rate of non–Q-wave MI was reduced only in patients undergoing surgery (7.1% versus 3.8%,P=0.005). There were no increases in clinically serious adverse events. Conclusions—No significant benefit of cariporide could be demonstrated across a wide range of clinical situations of risk. The trial documented safety of the drug and suggested that a high degree of inhibition of the exchanger could prevent cell necrosis in settings of ischemia-reperfusion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ryan, T. J., Faxon, D. P., Gunnar, R. M., Kennedy, J. W., King, S. B., Loop, F. D., Peterson, K. L., Reeves, T. J., Williams, D. O., & Winters, W. L. (1988) · Circulation · doi:10.1161/01.cir.78.2.486 · Cited by 2,123
Na+/H+ Exchangers of Mammalian Cells
Orlowski, J., & Grinstein, S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22373 · Cited by 575
Wallis, R. M., Corbin, J. D., Francis, S. H., & Ellis, P. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00042-9 · Cited by 504
Scholz, W. (1995) · Cardiovascular Research · doi:10.1016/0008-6363(96)88579-8 · Cited by 432
Rupprecht, H.-J., Dahl, J. V., Terres, W., Seyfarth, K. M., Richardt, G., Schultheiß, H.-P., Buerke, M., Sheehan, F. H., & Drexler, H. (2000) · Circulation · doi:10.1161/01.cir.101.25.2902 · Cited by 217
Gumina, R. J., Buerger, E., Eickmeier, C., Moore, J. M., Daemmgen, J. W., & Gross, G. J. (1999) · Circulation · doi:10.1161/01.cir.100.25.2519 · Cited by 146
CHAITMAN, B. R., Zhou, S., Tamesis, B. R., Rosen, A. D., Terry, A. B., Zumbehl, K. M., Stocke, K. S., Takase, B., Gussak, I. B., & Rautaharju, P. M. (1996) · Journal of Electrocardiology · doi:10.1016/s0022-0736(96)80091-4 · Cited by 37
Self-citationProtection of the myocardial cell during ischemia
Théroux, P. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00246-5 · Cited by 33
Senn (1998) · doi:10.1002/(sici)1097-0258(19980815/30)17:15/16
Cited by
Yellon, D. M., & Hausenloy, D. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071667 · Cited by 3,797
Interfering with pH regulation in tumours as a therapeutic strategy
Neri, D., & Supuran, C. T. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3554 · Cited by 1,547
Mechanisms Underlying Acute Protection From Cardiac Ischemia-Reperfusion Injury
Murphy, E., & Steenbergen, C. (2008) · Physiological Reviews · doi:10.1152/physrev.00024.2007 · Cited by 1,465
Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease
Del Re, D. P., Amgalan, D., Linkermann, A., Liu, Q., & Kitsis, R. N. (2019) · Physiological Reviews · doi:10.1152/physrev.00022.2018 · Cited by 961
Santos-Gallego, C. G., Requena-Ibanez, J. A., San Antonio, R., Ishikawa, K., Watanabe, S., Picatoste, B., Flores, E., Garcia-Ropero, A., Sanz, J., Hajjar, R. J., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.01.056 · Cited by 651
Pathogenesis of Myocardial Ischemia-Reperfusion Injury and Rationale for Therapy
Turer, A. T., & Hill, J. A. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.03.032 · Cited by 634
Ross, A. M., Gibbons, R. J., Stone, G. W., Kloner, R. A., & Alexander, R. W. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.061 · Cited by 610
Cardioprotection: chances and challenges of its translation to the clinic
Heusch, G. (2013) · The Lancet · doi:10.1016/s0140-6736(12)60916-7 · Cited by 546
Ovize, M., Baxter, G. F., Di Lisa, F., Ferdinandy, P., Garcia-Dorado, D., Hausenloy, D. J., Heusch, G., Vinten-Johansen, J., Yellon, D. M., & Schulz, R. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq129 · Cited by 502
Lytvyn, Y., Bjornstad, P., Udell, J. A., Lovshin, J. A., & Cherney, D. Z. I. (2017) · Circulation · doi:10.1161/circulationaha.117.030012 · Cited by 459
Fundamentals of Reperfusion Injury for the Clinical Cardiologist
Verma, S., Fedak, P. W. M., Weisel, R. D., Butany, J., Rao, V., Maitland, A., Li, R.-K., Dhillon, B., & Yau, T. M. (2002) · Circulation · doi:10.1161/01.cir.0000016602.96363.36 · Cited by 446
An overview of inhibitors of Na+/H+ exchanger
Masereel, B. (2003) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(03)00100-4 · Cited by 441
Myocardial Protection at a Crossroads: The Need for Translation Into Clinical Therapy
Bolli, R., Becker, L., Gross, G., Mentzer, R., Balshaw, D., & Lathrop, D. A. (2004) · Circulation Research · doi:10.1161/01.res.0000137171.97172.d7 · Cited by 428
Role of apoptosis in reperfusion injury
Eefting, F. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.12.023 · Cited by 418
Apple, F. S., Wu, A. H. B., & Jaffe, A. S. (2002) · American Heart Journal · doi:10.1067/mhj.2002.124048 · Cited by 397
Oxidative stress and neutrophil activation—the two keystones of ischemia/reperfusion injury
Kaminski, K. A., Bonda, T. A., Korecki, J., & Musial, W. J. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00189-4 · Cited by 340
Zeymer, U., Suryapranata, H., Monassier, J. P., Opolski, G., Davies, J., Rasmanis, G., Linssen, G., Tebbe, U., Schröder, R., Tiemann, R., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01608-4 · Cited by 337
Peri-procedural myocardial injury: 2005 update
Herrmann, J. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi455 · Cited by 325
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group I: Epidemiology
Howard, B. V., Rodriguez, B. L., Bennett, P. H., Harris, M. I., Hamman, R., Kuller, L. H., Pearson, T. A., & Wylie-Rosett, J. (2002) · Circulation · doi:10.1161/01.cir.0000013953.41667.09 · Cited by 308
Calcium-mediated cell death during myocardial reperfusion
Garcia-Dorado, D., Ruiz-Meana, M., Inserte, J., Rodriguez-Sinovas, A., & Piper, H. M. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs116 · Cited by 307
Schmidt, M. R., Smerup, M., Konstantinov, I. E., Shimizu, M., Li, J., Cheung, M., White, P. A., Kristiansen, S. B., Sorensen, K., Dzavik, V., et al. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00617.2006 · Cited by 277
Na+/h+exchange inhibitors for cardioprotective therapy: progress, problems and prospects
Avkiran, M., & Marber, M. S. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01693-5 · Cited by 269
Mentzer, R. M., Bartels, C., Bolli, R., Boyce, S., Buckberg, G. D., Chaitman, B., Haverich, A., Knight, J., Menasché, P., Myers, M. L., et al. (2008) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2007.10.054 · Cited by 264
Self-citationThe SLC9A-C Mammalian Na+/H+Exchanger Family: Molecules, Mechanisms, and Physiology
Pedersen, S. F., & Counillon, L. (2019) · Physiological Reviews · doi:10.1152/physrev.00028.2018 · Cited by 183
The role of omega-3 fatty acids in the secondary prevention of cardiovascular disease
Lee, K. W., & Lip, G. Y. H. (2003) · QJM · doi:10.1093/qjmed/hcg092 · Cited by 177
“One clinical trial of the specific Naþ=Hþ exchange inhibitor caporide showed a potential benefit in preventing the risk of cardiac death, providing that the drug was present prior to the index ischaemic event.(43) Other indirect anti-arrhythmic effects of longchain n–3 PUFAs may include lowering of the nonesterified f…”
BackgroundTraditional and emerging roles for the SLC9 na+/H+ exchangers
Fuster, D. G., & Alexander, R. T. (2014) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-013-1408-8 · Cited by 159
Myocardial ‘no-reflow’ — diagnosis, pathophysiology and treatment.
Wong, D. T. L., Puri, R., Richardson, J. D., Worthley, M. I., & Worthley, S. G. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.12.049 · Cited by 66
Chen, L., Chen, C. X., Gan, X. T., Beier, N., Scholz, W., & Karmazyn, M. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00602.2003 · Cited by 66
Metadata
- Authors
- Théroux, P., Chaitman, B. R., Danchin, N., Erhardt, L., Meinertz, T., Schroeder, J. S., Tognoni, G., White, H. D., Willerson, J. T., & Jessel, A.
- Venue
- Circulation
- Published
- 2000-12-19
- Volume
- 102
- Issue
- 25
- Pages
- 3032-3038
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2113440073
- Cited by
- 428
- References
- 9
- FWCI
- 22.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.